Hot Investor Mandate: China-Based, US-Specialized VC Seeks Opportunities in Early Stage to Pre-IPO Across All Life Science & Healthcare Industries

16 Apr

A specialized US venture capital firm under a holding group company focuses on finance, conducting business with its Chinese sister company as one group. The firm has headquarters in China and an additional virtual office in the U.S. The firm is actively seeking investment opportunities from early stage to pre-IPO rounds. The average size of investment is ~ $5M. The firm has invested in 17 US & Canada companies since 2016. The firm can act as the lead investor or co-investor depends on different cases, and the firm prefers to have a board seat.

The firm is a flexible and opportunistic investor that is currently considering Therapeutics, Medical Devices, and Diagnostics. The firm will also consider orphan drugs and digital health companies. The firm is open to all kinds of sectors. The firm is open to medical devices with all FDA regulatory pathways, including 510k and PMA. The firm is open to any phases in medical devices and therapeutics. However, the firm will invest in private companies only.

The firm has no specific requests on the management team. The firm generally takes a board seat.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: